Pharmaceutical Policy Experts™

divider

Accolades

The Inspector General and the President’s Council on Integrity and Efficiency recognized Rx|X founders several times for their reports and professional development.  Some of the highlights include:

  • Outstanding Inspection of the Year, “Cost Containment of Medicaid HIV/AIDS Drug Expenditures,” 2002
  • Inspector General’s Professional Development Award for professional stature as a valuable resource and facilitator on issues regarding drug pricing (M. Wallack), 2002
  • Inspector General’s Exceptional Achievement Award for significantly contributing to the OIG mission through the strategic development and completion of early implementation evaluations on the Temporary Medicare Drug Card Program, 2006
  • Inspector General’s Exceptional Achievement Award for rigorous and creative methodology used to review 340B Drug Program prices and explore causes for overcharges, 2007
  • President’s Council on Integrity & Efficiency Award of Excellence for the Evaluation of HRSA Oversight of the 340B Drug Discount Program, 2007
  • Inspector General’s Exceptional Achievement Award for innovative use of Geographic Information System technology to provide Congress with requested information on the extent of rural beneficiaries’ access to retail pharmacies, 2008
  • Inspector General’s Exceptional Achievement Award for major contributions toward OIG objectives in drug work, 2003